These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14010016)

  • 1. [A contribution to the problem of the antibacterial effect of the human vitreous body].
    ZEHETBAUER G
    Ophthalmologica; 1962; 143():196-200. PubMed ID: 14010016
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the problem of the antibacterial quality of the human vitreous body].
    ZANGGER J; MARX J
    Albrecht Von Graefes Arch Ophthalmol; 1960; 162():237-43. PubMed ID: 13787858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the antibacterial properties of the human vitreous body].
    ZEHETBAUER G
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1960; 137():747-52. PubMed ID: 13788089
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the liberation of bacteria-promoting substances from material containing receptors in the body by influenza A virus. A contribution to virus-bacteria synergism].
    STICKL H
    Z Hyg Infektionskr; 1962; 148():354-67. PubMed ID: 13917199
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth of Bacterium coli and Staphylococcus albus in heavy water.
    VAN HORN E; WARE GC
    Nature; 1959 Sep; 184(Suppl 11)():833. PubMed ID: 13841081
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors which control maximal growth of bacteria.
    SINCLAIR NA; STOKES JL
    J Bacteriol; 1962 May; 83(5):1147-54. PubMed ID: 13913264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DOES THE VITREOUS BODY POSSESS CULTIVATION AND BACTERIOSTATIC PROPERTIES?].
    ANIKINA VS
    Oftalmol Zh; 1964; 19():188-92. PubMed ID: 14211051
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.
    Robinson DA; Griffith RW; Shechtman D; Evans RB; Conzemius MG
    Acta Biomater; 2010 May; 6(5):1869-77. PubMed ID: 19818422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic activity of vitreous extract obtained from rabbit eyes with endotoxin-induced uveitis.
    Naveh N; Nussbaum A; Desatnik H; Bartov E
    Ophthalmic Res; 1995; 27(1):23-31. PubMed ID: 7596556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial growth in human vitreous humor.
    Egger SF; Buxbaum A; Georgopoulos M; Scholda C; Vecsei VP; Huber-Spitzy V; Georgopoulos A
    Exp Eye Res; 1997 Dec; 65(6):791-5. PubMed ID: 9441702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.
    Septama AW; Panichayupakaranant P
    Pharm Biol; 2016; 54(4):686-91. PubMed ID: 26427318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of the antibacterial effect of human vitreous.
    HILL K
    Trans Am Acad Ophthalmol Otolaryngol; 1960; 64():298-307. PubMed ID: 13852379
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereoisomers of cycloserine. III. The stability of the stereoisomers of the cycloserine in some culture media and in the presence or not of E. coli.
    PERLOTTO T; CONCILIO C
    Arch Int Pharmacodyn Ther; 1959 May; 120(1):48-52. PubMed ID: 13662036
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity pattern of natural and synthetic antibacterial agents among hospital isolates.
    Oloke JK
    Microbios; 2000; 102(403):175-81. PubMed ID: 10955832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial effects of previously infected or inflamed vitreous.
    Olarn RC; Aguilar HE; Wilson LA; Sawant A; Meredith TA
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2342-4. PubMed ID: 2122963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different application volumes of ethyl-cyanoacrylate tissue adhesive can change its antibacterial effects against ocular pathogens in vitro.
    Romero IL; Paiato TP; Silva CB; Nigro JB; Malta S; Jenne Mimica LM; Soong HK; Hida RY
    Curr Eye Res; 2008 Oct; 33(10):813-8. PubMed ID: 18853314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing incidence of antibiotic resistance among Staphylococcus aureus, Escherichia coli, Aerobacter-Klebsiella, and Pseudomonas encountered in a teaching hospital over a 7-year period.
    Bulger RJ; Roberts CE; Sherris JC
    Antimicrob Agents Chemother (Bethesda); 1966; 6():42-6. PubMed ID: 4860771
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diffusion of fluorescein in the vitreous body].
    SAMPAOLESI R
    Ophthalmologica; 1956; 131(4-5):359-64. PubMed ID: 13335117
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stability of cycloserine & its stereoisomers in bacteriological media].
    CONCILIO C; PERLOTTO T
    G Ital Chemioter; 1957; 4(3-4):504-7. PubMed ID: 13562596
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on capsules of Escherichia coli and Staphylococcus].
    KALUZEWSKI S
    Med Dosw Mikrobiol; 1954; 6(4):419-26. PubMed ID: 14355625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.